Enhanced efficiency of photodynamic therapy-mediated the plant pigment hypericin through Folate-PEG functionalized chitosan nanoparticles
Source abstract
Abstract
Hypericin (Hy), an anthraquinone-derived pigment, has recently attracted attention as a safe and natural photosensitizer for photodynamic therapy (PDT). However, its clinical applications have been limited by its hydrophobicity and off-target photoactivity. This work aimed to enhance efficacy of Hy-based PDT using a high-efficiency and high-specificity vehicle for targeted delivery Hy to the cancer cells. Hy-loaded chitosan nanoparticles (Hy-CNs) were prepared using the ionic gelation technique, and further functionalized with folic acid (FA) and PEG . These generated nanoparticles (PEG-FA-Hy-CNs) were physicochemically characterized using, FT-IR spectroscopy, UV–Vis spectroscopy, dynamic light scattering , and SEM analysis and then compared with other Hy formulations in terms the singlet oxygen production, intra cellular uptake, and phototoxicity under suitable irradiation (590 nm, 10 Jcm −2 ). All the formed nanostructures presented a mean particle size about 200–300 nm and greater than 80 % entrapment efficiency. Drug release data of PEG-FA-Hy-CNs indicated a sustained release of Hy and a good correlation with Higuchi model. PEG-FA-Hy-CNs induced a much higher singlet oxygen formation, cellular uptake, photoactivity, and apoptosis compared to Hy-CN, Hy-FA, Hy-PEG, and free Hy. Additionally, these effects were much higher in FA receptors over-expressing breast cancer cells than healthy cell lines. Results suggest that PEG-FA-Hy-CNs can be used for controlled Hy release and active targeting of breast cancer cells, which are beneficial for Hy-based PDT.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Photodynamic Therapy Research Studies · Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (56)
Show source-provided references
1. Breast cancer treatments: updates and new challenges10.3390/jpm11080808 ↗
2. Beyond chemotherapies: recent strategies in breast cancer treatment10.3390/cancers12092634 ↗
3. Anticancer chemotherapy and radiotherapy trigger both non-cell-autonomous and cell-autonomous death10.1038/s41419-018-0747-y ↗
4. Photodynamic therapy in cancer treatment - an update review
5. Insight on pyrimido[5,4-g] indolizine and pyrimido[4,5-c]pyrrolo[1,2-a]azepine systems as promising photosensitizers on malignant cells10.1016/j.ejmech.2022.114399 ↗
6. Hypericin: source, determination, separation, and properties10.1080/15422119.2020.1797792 ↗
7. Phytochemical profiles, phototoxic and antioxidant properties of eleven Hypericum species-a comparative study10.1016/j.phytochem.2018.05.003 ↗
8. Do other Hypericum species have medical potential as St. John's Wort (Hypericum perforatum)? Curr. Med
9. Hypericin-mediated photodynamic therapy for the treatment of cancer: a review
10. Bioavailability enhancement of poorly water-soluble drugs via nanocomposites: formulation-Processing aspects and challenges10.3390/pharmaceutics10030086 ↗
11. Current advances in chitosan nanoparticles based drug delivery and targeting10.15171/apb.2019.023 ↗
12. Chitosan-based nanomaterials for drug delivery10.3390/molecules23102661 ↗
13. Chitosan-based nanoparticles of targeted drug delivery system in breast cancer treatment10.3390/polym13111717 ↗
14. Nanoparticle surface functionalization: how to improve biocompatibility and cellular internalization10.3389/fmolb.2020.587012 ↗
15. Antibody conjugation of nanoparticles as therapeutics for breast cancer treatment10.3390/ijms21176018 ↗
16. Recent advancement of molecular structure and biomaterial function of chitosan from marine organisms for pharmaceutical and nutraceutical application10.3390/app10144719 ↗
17. Folic acid-conjugated mesoporous silica nanoparticles for enhanced therapeutic efficacy of topotecan in retina cancers10.2147/IJN.S142668 ↗
18. Folate receptor as a biomarker and therapeutic target in solid tumors10.1016/j.currproblcancer.2022.100917 ↗
19. Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response10.1016/j.molonc.2011.11.010 ↗
20. Folate receptor alpha expression in lung cancer: diagnostic and prognostic significance10.18632/oncotarget.519 ↗
21. Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery10.1039/D1NR02065J ↗
22. Pegylation: an important approach for novel drug delivery system10.1080/09205063.2020.1825304 ↗
23. Engineering folate–drug conjugates to target cancer: from chemistry to clinic10.1021/bc2005522 ↗
24. Folic acid conjugated guar gum nanoparticles for targeting methotrexate to colon cancer10.1166/jbn.2013.1474 ↗
25. Folate-PEG conjugates of a far-red light-activatable paclitaxel prodrug to improve selectivity toward folate receptor-positive cancer cells10.1021/acsomega.7b01105 ↗
26. Both FA- and mPEG-conjugated chitosan nanoparticles for targeted cellular uptake and enhanced tumor tissue distribution10.1186/1556-276X-6-563 ↗
27. Design, synthesis and biological evaluation of folate-porphyrin: a new photosensitizer for targeted photodynamic therapy10.1142/S1088424610002379 ↗
28. PEGylation of shellac-based nanocarriers for enhanced colloidal stability10.1016/j.colsurfb.2019.110434 ↗
29. PEGylated nanocarriers: a promising tool for targeted delivery to the brain10.1016/j.colsurfb.2019.110770 ↗
30. Development and characterization of folic acid-conjugated chitosan nanoparticles for targeted and controlled delivery of gemcitabinein lung cancer therapeutics10.1080/21691401.2016.1260578 ↗
31. Dynamic light scattering of nano-gels of xanthan gum biopolymer in colloidal dispersion10.1016/j.jare.2016.06.009 ↗
32. Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer10.1016/j.ijpharm.2006.07.012 ↗
33. Release kinetics study of poorly water-soluble drugs from nanoparticles: are we doing it right?10.1021/mp500817h ↗
34. Mathematical modeling of drug release from swellable polymeric nanoparticles
35. The Development of 1, 3-Diphenylisobenzofuran as a highly selective probe for the detection and quantitative determination of hydrogen peroxide
36. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays10.1016/0022-1759(83)90303-4 ↗
37. Self-assembled peptide-paclitaxel nanoparticles for enhancing therapeutic efficacy in colorectal cancer
38. Sesamin induces A549 cell mitophagy and mitochondrial apoptosis via a reactive oxygen species-mediated reduction in mitochondrial membrane potential10.4196/kjpp.2020.24.3.223 ↗
39. Nanoparticulated formulations of St. John's wort (Hypericum perforatum L.) as smart drug delivery system combating depression incited in mice models10.56499/jppres16.193_5.3.187 ↗
40. Structural characterization and in vitro biomedical activities of sulfated chitosan from Sepia pharaonis10.1016/j.ijbiomac.2015.12.030 ↗
41. Effect of chitosan and chitosan-nanoparticles on post harvest quality of banana fruits10.5010/JPB.2018.45.1.036 ↗
42. Hypericin-bearing magnetic iron oxide nanoparticles for selective drug delivery in photodynamic therapy10.2147/IJN.S92336 ↗
43. Evaluation of hypericin-loaded solid lipid nanoparticles: physicochemical properties, photostability and phototoxicity10.3109/10837450.2010.529148 ↗
44. Hypericin encapsulated in solid lipid nanoparticles: phototoxicity and photodynamic efficiency10.1016/j.jphotobiol.2013.05.010 ↗
45. Drug release study of the chitosan-based nanoparticles10.1016/j.heliyon.2021.e08674 ↗
46. 5-fluorouracil encapsulated chitosan nanoparticles for pH-stimulated drug delivery: evaluation of controlled release kinetics
47. Kinetic modeling on drug release from controlled drug delivery systems
48. Drug transport mechanisms and in vitro release kinetics of vancomycin encapsulated chitosan-alginate polyelectrolyte microparticles as a controlled drug delivery system10.1016/j.ejps.2017.12.012 ↗
49. The detection sensitivity of commonly used singlet oxygen probes in aqueous environments10.1016/j.jphotobiol.2020.111787 ↗
50. Hypericin-loaded chitosan nanoparticles for enhanced photodynamic therapy in A549 lung cancer cells10.1007/s12668-023-01099-w ↗
51. Conjugation of hypericin to gold nanoparticles for enhancement of photodynamic therapy in MCF-7 breast cancer cells10.3390/pharmaceutics14102212 ↗
52. Analysis of hypericin mediated effects and implications for targeted photodynamic therapy10.3390/ijms18071388 ↗
53. Intracellular delivery and ultrasonic activation of folate receptor-targeted phase-change contrast agents in breast cancer cells in vitro10.1016/j.jconrel.2016.09.010 ↗
54. Identification of a peptide for folate receptor alpha by phage display and its tumor targeting activity in ovary cancer xenograft10.1038/s41598-018-26683-z ↗
55. Targeted proteomics enables simultaneous quantification of folate receptor isoforms and potential isoform-based diagnostics in breast cancer
56. Multifunctional core–shell upconversion nanoparticles for targeted tumor cells induced by near-infrared light10.1039/c3tb00575e ↗